Skip to main content
Veeva Systems Inc (VEEV)
Computer Software and Services Information Technology
Stock AI

Veeva Systems Expands Partnership with Roche: A Leap into AI-Enabled CRM

Last updated: November 24, 2025
Taurigo

1. Strengthening Ties

In a significant move within the life sciences sector, Veeva Systems Inc. (NYSE: VEEV) announced on November 24, 2025, the extension of its longstanding partnership with Roche Pharmaceuticals. The latest development involves Roche adopting Veeva's Vault CRM, a decision that underscores the ongoing collaboration between the two companies, which have been partners for several years.

"Roche and Veeva have partnered for many years," stated Veeva CEO Peter Gassner. "We are honored to extend our partnership to Vault CRM and bring the next generation of AI-enabled CRM to the global Roche Pharma field teams." This sentiment reflects not only the trust that Roche has in Veeva's capabilities but also the mutual commitment to advancing technology in the pharmaceutical industry.

2. The Power of Vault CRM

Veeva's Vault CRM is part of a comprehensive suite of applications designed to enhance commercial execution in life sciences. This solution leverages data and artificial intelligence (AI) to facilitate more personalized interactions between pharmaceutical representatives and healthcare professionals. Wafaa Mamilli, Roche's Chief Digital and Technology Officer, expressed enthusiasm about the partnership, emphasizing that "with data and AI at its core, Vault CRM will help us create more personalized interactions, giving our teams the insights to better support healthcare professionals and the patients they serve."

The integration of Veeva's AI technology into the CRM system is expected to revolutionize how Roche's field teams operate, enabling them to make informed decisions based on real-time data and insights.

3. Upcoming AI Features

Veeva is set to introduce several AI Agents for the Vault CRM, including Free Text Agent, Voice Agent, Pre-call Agent, and Media Agent, with availability planned for December 2025. These AI-driven features are designed to enhance user experience and improve the efficiency of interactions by providing critical information and support at pivotal moments.

4. Veeva's Commitment to Innovation

Veeva Systems is recognized for delivering cloud-based solutions tailored specifically for the life sciences industry. The company has a strong commitment to innovation and customer success, serving over 1,500 clients that range from large biopharmaceutical corporations to emerging biotech firms. As a Public Benefit Corporation, Veeva emphasizes the importance of balancing the interests of all its stakeholders, including customers, employees, and shareholders.

5. Conclusion

The expanded partnership between Veeva Systems and Roche Pharmaceuticals marks a significant step in the evolution of customer relationship management in the pharmaceutical sector. By integrating advanced AI capabilities into their CRM processes, Roche aims to enhance its interactions with healthcare professionals and ultimately provide better support for patients. As the life sciences industry continues to embrace technology and data-driven solutions, the collaboration between these two companies will likely set a benchmark for future innovations in the field.

For further information on Veeva Systems and its offerings, interested parties can visit veeva.com.

You may also be interested in:
Copyright ©2026 Taurigo GmbH. All rights reserved.Taurigo GmbH provides no investment advice. Any analyses, research, ideas, prices, or other information contained on this website are provided as general market information for educational and entertainment purposes only, and do not constitute investment advice. We assume no responsibility for the accuracy, completeness or timeliness of any financial information contained on this site. In particular, we do not constitute an invitation to buy, sell or hold securities or other financial products. We shall not be liable for any loss or damage, including without limitation loss of profits, arising directly or indirectly from use of or reliance on the provided information. Before making any investment decision, you should consider whether it is suitable for your situation and obtain appropriate financial, tax and legal advice.